Home / Accomplishment

What the network produced

An expanding portfolio of cross-national evidence

ASCVD establishes the cross-database study-preparedness framework, AD/PN extends it to another therapeutic area, and the transportability study examines whether evidence can inform a second national setting while preserving context and uncertainty.

Evidence register

Explore the case studies

Case 01 · ASCVD

Risk patterns across East Asian data environments

11.21.41.6NHIRD1.51NHIS1.47CGRD1.49DeSC1.17CDARS1.16HR (95% CI), ASCVD recurrence

Recurrent cardiovascular risk compared between very-high-risk and high-risk patients across national claims and hospital record environments.

EstablishCross-database comparability
Read more →
Extended case · ASCVD visualization

Explore standardized aggregate outputs interactively

051012.47.8ASCVD recurrence9.75.8Major CV events3.31.6ACSVery-high-riskHigh-riskIncidence per 100 person-years

Review current study results for cohort assembly, baseline characteristics, event rates, and comparative estimates through one consistent data contract.

ExploreInteractive output review
Open the visualization →
Case 02 · AD / PN

A reusable framework across therapeutic areas

0%25%50%D1D2D3NHIRDHIRADeSCCGRDAdult AD prevalence, 2020

Disease burden, standard of care, and clinical outcomes characterized in atopic dermatitis and prurigo nodularis while preserving site-specific disease algorithms.

ExpandReusable study machinery
Read more →
Case 03 · Transportability

Can evidence travel from Taiwan to Japan?

0.60.811.21.4TW obs.0.81Transported0.95JP obs.1.12RR (95% CI), MACE · prasugrel vs clopidogrel

A retrospective target-trial emulation compares Taiwan NHIRD and Japan DeSC estimates, then examines estimates transported by a model developed in Taiwan.

ExtendEvidence transportability
Read more →